The nimbleness of biotechs makes them well suited to implementing QbD. Here's how to get started.
Todd Hein
Advertisement
Todd Hein is the senior director of life sciences at Oracle Corporation
Articles by Todd Hein
Advertisement
Latest Updated Articles
QbD: A Roadmap to AdoptionJanuary 1st 2010
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Zylidac Bio to Scale Prolific's Optogenetic Cell Line Platform to GMP
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5